Latest Drugs, Latest Approval in Echinocandins

What are Echinocandins?

Echinocandins are a class of antifungal drugs that target the fungal cell wall. They are lipopeptide molecules that noncompetitively inhibit (1,3) beta-d-glucan synthase enzyme. This enzyme forms glucan, a major component of the fungal cell wall therefore by inhibiting its synthesis fungal cell walls are damaged.

Name Updated
Caspofungin (Caspofungin [ kas-poe-fun-jin ]) 16-Aug-2023
Anidulafungin (Anidulafungin [ ay-nid-ue-la-fun-gin ]) 15-Aug-2023
Rezafungin (Rezafungin [ re-za-fun-jin ]) 12-Aug-2023
Micafungin (Micafungin [ mye-ka-fun-jen ]) 11-Aug-2023
Rezzayo (Rezafungin) 14-Jul-2023
Mycamine (Micafungin [ mye-ka-fun-jen ]) 13-Jul-2023
Eraxis (Anidulafungin [ ay-nid-ue-la-fun-gin ]) 13-Jul-2023
Cancidas (Caspofungin [ kas-poe-fun-jin ]) 13-Jul-2023